255 related articles for article (PubMed ID: 31918287)
1. Immunosuppressive Siglec-E ligands on mouse aorta are up-regulated by LPS via NF-κB pathway.
Liu H; Zheng Y; Zhang Y; Li J; Fernandes SM; Zeng D; Li X; Schnaar RL; Jia Y
Biomed Pharmacother; 2020 Feb; 122():109760. PubMed ID: 31918287
[TBL] [Abstract][Full Text] [Related]
2. Immunoregulatory Siglec ligands are abundant in human and mouse aorta and are up-regulated by high glucose.
Zhang Y; Zheng Y; Li J; Nie L; Hu Y; Wang F; Liu H; Fernandes SM; Zhong Q; Li X; Schnaar RL; Jia Y
Life Sci; 2019 Jan; 216():189-199. PubMed ID: 30471282
[TBL] [Abstract][Full Text] [Related]
3. Studies on the Detection, Expression, Glycosylation, Dimerization, and Ligand Binding Properties of Mouse Siglec-E.
Siddiqui S; Schwarz F; Springer S; Khedri Z; Yu H; Deng L; Verhagen A; Naito-Matsui Y; Jiang W; Kim D; Zhou J; Ding B; Chen X; Varki N; Varki A
J Biol Chem; 2017 Jan; 292(3):1029-1037. PubMed ID: 27920204
[TBL] [Abstract][Full Text] [Related]
4. Siglec-8 and Siglec-9 binding specificities and endogenous airway ligand distributions and properties.
Yu H; Gonzalez-Gil A; Wei Y; Fernandes SM; Porell RN; Vajn K; Paulson JC; Nycholat CM; Schnaar RL
Glycobiology; 2017 Jul; 27(7):657-668. PubMed ID: 28369504
[TBL] [Abstract][Full Text] [Related]
5. Sialic Acid-Siglec-E Interactions During
Mukherjee K; Khatua B; Mandal C
Front Immunol; 2020; 11():332. PubMed ID: 32184783
[No Abstract] [Full Text] [Related]
6. Soluble Siglec-9 alleviates intestinal inflammation through inhibition of the NF-κB pathway.
Kang EA; Soh H; Park S; Lee HJ; Im JP; Kim JS
Int Immunopharmacol; 2020 Sep; 86():106695. PubMed ID: 32570035
[TBL] [Abstract][Full Text] [Related]
7. Expression of ligands for Siglec-8 and Siglec-9 in human airways and airway cells.
Jia Y; Yu H; Fernandes SM; Wei Y; Gonzalez-Gil A; Motari MG; Vajn K; Stevens WW; Peters AT; Bochner BS; Kern RC; Schleimer RP; Schnaar RL
J Allergy Clin Immunol; 2015 Mar; 135(3):799-810.e7. PubMed ID: 25747723
[TBL] [Abstract][Full Text] [Related]
8. Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer.
Läubli H; Pearce OM; Schwarz F; Siddiqui SS; Deng L; Stanczak MA; Deng L; Verhagen A; Secrest P; Lusk C; Schwartz AG; Varki NM; Bui JD; Varki A
Proc Natl Acad Sci U S A; 2014 Sep; 111(39):14211-6. PubMed ID: 25225409
[TBL] [Abstract][Full Text] [Related]
9. Supplementing Glucose Intake Reverses the Inflammation Induced by a High-Fat Diet by Increasing the Expression of Siglec-E Ligands on Erythrocytes.
Liu H; Li J; Wu N; She Y; Luo Y; Huang Y; Quan H; Fu W; Li X; Zeng D; Jia Y
Inflammation; 2024 Apr; 47(2):609-625. PubMed ID: 38448631
[TBL] [Abstract][Full Text] [Related]
10. Constitutively expressed Siglec-9 inhibits LPS-induced CCR7, but enhances IL-4-induced CD200R expression in human macrophages.
Higuchi H; Shoji T; Iijima S; Nishijima K
Biosci Biotechnol Biochem; 2016 Jun; 80(6):1141-8. PubMed ID: 26923638
[TBL] [Abstract][Full Text] [Related]
11. ING4 alleviated lipopolysaccharide-induced inflammation by regulating the NF-κB pathway via a direct interaction with SIRT1.
Yang Y; Liu Y; He X; Yang F; Han S; Qin A; Wu G; Liu M; Li Z; Wang J; Yang X; Hu D
Immunol Cell Biol; 2020 Feb; 98(2):127-137. PubMed ID: 31811786
[TBL] [Abstract][Full Text] [Related]
12. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9.
Rodriguez E; Boelaars K; Brown K; Eveline Li RJ; Kruijssen L; Bruijns SCM; van Ee T; Schetters STT; Crommentuijn MHW; van der Horst JC; van Grieken NCT; van Vliet SJ; Kazemier G; Giovannetti E; Garcia-Vallejo JJ; van Kooyk Y
Nat Commun; 2021 Feb; 12(1):1270. PubMed ID: 33627655
[TBL] [Abstract][Full Text] [Related]
13. Siglec-E is up-regulated and phosphorylated following lipopolysaccharide stimulation in order to limit TLR-driven cytokine production.
Boyd CR; Orr SJ; Spence S; Burrows JF; Elliott J; Carroll HP; Brennan K; Ní Gabhann J; Coulter WA; Jones C; Crocker PR; Johnston JA; Jefferies CA
J Immunol; 2009 Dec; 183(12):7703-9. PubMed ID: 19933851
[TBL] [Abstract][Full Text] [Related]
14. Nauclea officinalis inhibits inflammation in LPS-mediated RAW 264.7 macrophages by suppressing the NF-κB signaling pathway.
Zhai XT; Zhang ZY; Jiang CH; Chen JQ; Ye JQ; Jia XB; Yang Y; Ni Q; Wang SX; Song J; Zhu FX
J Ethnopharmacol; 2016 May; 183():159-165. PubMed ID: 26806575
[TBL] [Abstract][Full Text] [Related]
15. Induction of the endogenous sialoglycan ligand for eosinophil death receptor Siglec-8 in chronic rhinosinusitis with hyperplastic nasal polyposis.
Lee HS; Gonzalez-Gil A; Drake V; Li TA; Schnaar RL; Kim J
Glycobiology; 2021 Sep; 31(8):1026-1036. PubMed ID: 33755113
[TBL] [Abstract][Full Text] [Related]
16. Blockade of nuclear factor-kappaB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera.
Lee JH; Jung HS; Giang PM; Jin X; Lee S; Son PT; Lee D; Hong YS; Lee K; Lee JJ
J Pharmacol Exp Ther; 2006 Jan; 316(1):271-8. PubMed ID: 16183703
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK-NF-κB pathway.
Zhao W; Ma G; Chen X
Vascul Pharmacol; 2014 Dec; 63(3):162-72. PubMed ID: 25135647
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory effects of guggulsterone on murine macrophage by inhibiting LPS-induced inflammatory cytokines in NF-κB signaling pathway.
Zhang JH; Shangguan ZS; Chen C; Zhang HJ; Lin Y
Drug Des Devel Ther; 2016; 10():1829-35. PubMed ID: 27330276
[TBL] [Abstract][Full Text] [Related]
19. Luteolin protects against vascular inflammation in mice and TNF-alpha-induced monocyte adhesion to endothelial cells via suppressing IΚBα/NF-κB signaling pathway.
Jia Z; Nallasamy P; Liu D; Shah H; Li JZ; Chitrakar R; Si H; McCormick J; Zhu H; Zhen W; Li Y
J Nutr Biochem; 2015 Mar; 26(3):293-302. PubMed ID: 25577468
[TBL] [Abstract][Full Text] [Related]
20. Colonic epithelial cells express specific ligands for mucosal macrophage immunosuppressive receptors siglec-7 and -9.
Miyazaki K; Sakuma K; Kawamura YI; Izawa M; Ohmori K; Mitsuki M; Yamaji T; Hashimoto Y; Suzuki A; Saito Y; Dohi T; Kannagi R
J Immunol; 2012 May; 188(9):4690-700. PubMed ID: 22467657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
